Skip to main content
Clinical Trials/ChiCTR2200064506
ChiCTR2200064506Not yet recruitingUnknown

环泊酚在全麻手术患者的应用观察

Not provided1 site in 1 country160 target enrollmentStarted: October 10, 2022Last updated:

Trial Snapshot

Phase
Unknown
Status
Not yet recruiting
Enrollment
160
Locations
1
Primary Endpoint
镇静成功例数

Study Overview

Brief Summary

比较不同剂量环泊酚在无痛胃镜检查中的应用效果,探讨合理剂量,为临床提供参考。

Study Design

Study Type
Interventional
Primary Purpose
不同剂量对照

Eligibility Criteria

Ages
18 to 64 (—)
Sex
All

Inclusion Criteria

  • 接受无痛胃镜检查的患者,性别不限,年龄 18~64 岁,BMI 18~30 kg/m2,ASA Ⅰ或Ⅱ级;
  • 自愿参与本研究者,并自愿签署知情同意书。

Exclusion Criteria

  • 既往对环泊酚、丙泊酚药物过敏;
  • 合并精神疾病,肝肾功能异常;

Arms & Interventions

C1

静脉注射环泊酚 0.4 mg/kg

C2

静脉注射环泊酚 0.5 mg/kg

C3

静脉注射环泊酚 0.6 mg/kg

P

静脉注射丙泊酚 2mg/kg

Outcomes

Primary Outcomes

镇静成功例数

环泊酚或丙泊酚追加例数

苏醒时间

离院时间

心率

收缩压

舒张压

脉搏氧饱和度

Secondary Outcomes

  • 不良反应

Investigators

Study Sites (1)

Loading locations...

Similar Trials